Screener examples › Investor Playbooks
Minervini-style trend template
Stage-two uptrends with relative strength. Inspired by Mark Minervini's published method; not affiliated or endorsed.
“Stocks over $1B above their 50-day and 200-day moving averages, at least 30% above their 52-week low, within 25% of their 52-week high, with RS rating above 70, strongest RS rating first”
Run this screen live and refine it in plain English (free, no sign-up).
US stocks over $1B in uptrends, well off their lows and near highs, ranked by RS rating.
Filters: Market cap > $1B; Price above 50-day SMA; Price above 200-day SMA; At least 30% above 52-week low; Within 25% of 52-week high; RS rating > 70
Top matches on data as of November 4, 2026
| Symbol | Company | RS Rating | Market Cap (USD) | Price | SMA 50 | SMA 200 | % from 52W Low | From 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 99 | $100.0B | $252.58 | $187.78 | $89.50 | 10.3% | -2.4% | $22.28 |
| KOD | Kodiak Sciences Inc. | 99 | $6.1B | $97.78 | $67.32 | $43.17 | 5.2% | -6.0% | $15.83 |
| CDNA | CareDx, Inc | 99 | $4.3B | $81.62 | $62.20 | $34.64 | 4.7% | -10.2% | $14.27 |
| AGL | Agilon Health, Inc. | 99 | $2.0B | $118.19 | $87.55 | $65.97 | 14.8% | -11.2% | $7.48 |
| REPL | Replimune Group, Inc. | 99 | $1.9B | $20.36 | $13.89 | $9.49 | 12.6% | -4.3% | $1.50 |
| GMAB | Genmab A/S | 98 | $32.8B | $54.75 | $38.41 | $30.84 | 131.8% | -8.7% | $23.62 |
| GKOS | Glaukos Corporation | 98 | $14.5B | $245.01 | $176.62 | $143.25 | 2.0% | -4.0% | $80.91 |
| OSCR | Oscar Health, Inc. | 98 | $10.9B | $36.14 | $31.79 | $23.84 | 2.4% | -0.1% | $10.69 |
| SSL | Sasol Limited | 98 | $10.6B | $15.40 | $14.66 | $12.03 | 1.6% | -15.4% | $5.97 |
| HNGE | Hinge Health, Inc. | 98 | $9.5B | $120.21 | $99.87 | $68.18 | 3.0% | -3.8% | $30.08 |
| VSXY | Victoria's Secret & Company | 98 | $9.0B | $106.91 | $86.39 | $70.33 | 2.2% | -2.6% | $33.61 |
| SYRE | Spyre Therapeutics, Inc. | 98 | $8.3B | $97.43 | $89.52 | $74.19 | 3.6% | -11.6% | $21.15 |
| PACS | PACS Group, Inc. | 98 | $8.0B | $50.62 | $44.39 | $39.86 | 3.9% | -2.1% | $10.31 |
| TBBB | BBB Foods Inc. | 98 | $7.7B | $64.75 | $53.86 | $42.35 | 1.5% | -0.6% | $25.84 |
| ANF | Abercrombie & Fitch Co. | 98 | $7.3B | $165.71 | $147.20 | $105.60 | 1.5% | -3.6% | $65.45 |
| ORKA | Oruka Therapeutics, Inc. | 98 | $6.3B | $99.46 | $88.16 | $70.22 | 2.9% | -13.9% | $25.23 |
| HAE | Haemonetics Corporation | 98 | $5.8B | $126.48 | $110.82 | $79.39 | 1.5% | -1.7% | $49.96 |
| LFST | LifeStance Health Group, Inc. | 98 | $5.8B | $15.10 | $12.56 | $9.43 | 2.2% | 5.5% | $4.79 |
| GRAL | GRAIL Inc. | 98 | $5.4B | $126.35 | $115.55 | $78.67 | 2.0% | -24.1% | $41.50 |
| BRZE | Braze, Inc. | 98 | $5.0B | $46.07 | $32.09 | $24.93 | 2.0% | -0.2% | $15.26 |
| HTFL | Heartflow, Inc. Common Stock | 98 | $4.7B | $54.75 | $51.13 | $34.41 | 1.7% | -9.6% | $20.13 |
| PLSE | Pulse Biosciences, Inc. | 98 | $3.8B | $55.17 | $51.35 | $31.95 | 3.4% | -6.3% | $12.56 |
| APPN | Appian Corporation | 98 | $3.8B | $51.74 | $41.03 | $29.24 | 1.8% | -4.4% | $18.63 |
| FIGS | FIGS, Inc. | 98 | $3.6B | $21.48 | $16.16 | $13.59 | 1.9% | -4.4% | $7.31 |
| ECO | Okeanis Eco Tankers Corp. | 98 | $3.5B | $86.06 | $83.90 | $59.77 | 1.7% | -16.1% | $31.75 |
25 matches. Research data, not investment advice.